SJP-L-5
SJP-L-5 is a novel HIV-1 capsid dissociation inhibitor (EC50 = 0.16-0.97 μg/mL) . SJP-L-5 inhibits viral infection by blocking the entry of HIV-1 viral DNA into the nucleus. SJP-L-5 can be used for research on viral infections[1].
Product Specifications
CAS Number
1286237-83-9
UNSPSC
12352005
Target
HIV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(C1=C(C2=CC=C(N(C)C)C=C2)C(OC)=C3OCOC3=C1)OC
Molecular Formula
C18H19NO5
Molecular Weight
329.35
References & Citations
[1] Bai R, et al. SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry. BMC Microbiol. 2015 Dec 2;15:274.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
